|

REXULTI Drug General Use-results Survey (Excessive Motor Activity or Physically/Verbally Aggressive Behavior Due to Rapid Changes in Mood, Irritability, and/or Outbursts Associated With Dementia Due to Alzheimer's Disease)

RECRUITINGSponsored by Otsuka Pharmaceutical Co., Ltd.
Actively Recruiting
SponsorOtsuka Pharmaceutical Co., Ltd.
Started2025-04-17
Est. completion2027-09-30
Eligibility
Age15 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06875986

Summary

The purpose of this study is to evaluate safety of REXULTI in patients under daily clinical settings. In addition, information on efficacy will be collected.

Eligibility

Age: 15 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients diagnosed with Alzheimer's disease

Exclusion Criteria:

\-

Conditions2

Alzheimer DiseaseAlzheimer's Disease

Browse More Trials

Alzheimer's Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.